© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Conference Coverage
Consider switch to clopidogrel for DAPT early post ACS
AT EuroPCR
AT EuroPCR
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase 2a study.